Table 2.
miR-132 expression and clinicopathological factors
| Variables | High expression n = 33 | Low expression n =46 | P |
|---|---|---|---|
| Gender |
|
|
0.618 |
| Male |
25 |
37 |
|
| Female |
8 |
9 |
|
| Age |
|
|
0.556 |
| <60 |
18 |
22 |
|
| ≥60 |
15 |
24 |
|
| Histological grading |
|
|
0.412 |
| Poorly-differentiated |
28 |
36 |
|
| Moderately-differentiated |
5 |
7 |
|
| Well-differentiated |
0 |
3 |
|
| Tumor location |
|
|
0.467 |
| Upper third |
10 |
15 |
|
| Middle third |
8 |
7 |
|
| Lower third |
15 |
21 |
|
| Two-third or more |
0 |
3 |
|
| Tumor size (cm) |
|
|
0.862 |
| <5 |
18 |
26 |
|
| ≥5 |
15 |
20 |
|
| Nervous invasion |
|
|
0.096 |
| Yes |
22 |
22 |
|
| No |
11 |
24 |
|
| Lymphatic tumor emboli |
|
|
0.005 |
| Yes |
26 |
22 |
|
| No |
7 |
24 |
|
| T stage |
|
|
0.070 |
| T1,T2 |
6 |
17 |
|
| T3,T4 |
27 |
29 |
|
| Lymph node metastasis |
|
|
0.033 |
| Yes |
28 |
29 |
|
| No |
5 |
17 |
|
| Pathological stage |
|
|
0.016 |
| I |
2 |
8 |
|
| II |
6 |
18 |
|
| III | 25 | 20 |